Company Research Report: Neurosoft Bioelectronics

Company Overview

• Name: Neurosoft Bioelectronics

• Mission: To build minimally invasive brain interfaces to monitor, treat, and restore lost functions for individuals fighting neurological disorders.

• Founded: 2018

• Founders: Nicolas Vachicouras (CEO & Co-Founder), Ludovic Serex (CTO & Co-Founder)

• Key People:

• Nicolas Vachicouras (CEO & Co-Founder)

• Ludovic Serex (CTO & Co-Founder)

• Olivia Molloy (Manufacturing Manager)

• Chloé Fattebert (Quality & Regulatory Affairs Manager)

• Karolina Janikowska (Clinical Affairs Manager)

• Alexandre Michalis (Head of Product Development)

• Headquarters: Geneva, Switzerland

• Number of Employees: No information is available.

• Revenue: No information is available.

• Company Industry & Known For: Neurosoft Bioelectronics is known for its pioneering work in developing soft, elastic brain interfaces using their proprietary Brain-Computer Interface (BCI) technology, which focuses on enhanced bio-integration and minimizing mechanical mismatch with neural tissue.

Products

SOFT ECoG™

• Description: A family of subdural electrodes for brain signal recording or stimulation, intra-operatively or up to 30 days.

• Key Features:

• Built on soft brain interface technology offering flexibility and stretchability.

• Used for identifying epileptogenic brain tissue and mapping during surgeries.

MINDZ™

• Description: A brain interface that can be implanted using a minimally invasive system.

• Key Features:

• Supports localization of epileptic foci in drug-resistant epilepsy.

• Reduces surgery and recovery times through a minimally invasive burr hole insertion.

SOFT TINNIT™

• Description: First brain interface system developed to treat severe tinnitus.

• Key Features:

• Implantable closed-loop system targeting specific brain areas for modulation.

• Aims to reduce or suppress tinnitus symptoms.

Synapsuit

• Description: BCI to assist individuals with severe upper-limb disabilities.

• Key Features:

• Combines brain signal decoding via AI with wearable exosuit technology.

• Real-time support for upper limb control through collaboration with research institutions.

Recent Developments

• New Partnerships & Collaborations:

• Collaborating with the Wyss Center, Korea Electronics Technology Institute, Jang EUN FnC for the Synapsuit project.

• New Products Launched: No specific new product launches were mentioned.

• New Features Added to Existing Products: No information is available.

• Awards & Recognition:

• Participated in the TOP 100 Swiss Startup Award 2024.

• Featured in various prominent articles highlighting their transformative technology and soft implantable electrodes.

Research & Achievements

• Publications & Patents:

• Over 20 peer-reviewed articles and 25 patents related to innovative neuroprosthetic interfaces and soft electrode technologies.

• Recognition & Media Coverage:

• Featured in numerous articles and podcasts recognizing innovations in brain-computer interface technologies and their potential impacts on healthcare.

Manufacturing and Quality Standards

• Manufacturing Facilities: Located at Campus Biotech, Geneva, Switzerland.

• Capabilities:

• Employs semiconductor processes for precision manufacturing.

• Facilities include ISO 5 and 7 cleanrooms, adhering to Good Manufacturing Practices (GMP) and ISO 13485.

Contact Information

• Locations:

• Geneva, Switzerland: Campus Biotech, Chemin des Mines 9, 1202 Geneva

• New York, USA: 169 Madison Ave # 11497, New York, NY 10016

• Email: contact@neurosoft-bio.com

Note: Neurosoft Bioelectronics' brain interfaces are investigational devices and are not yet available for sale in the United States and Europe.